Detection of an Influenza B Virus Strain with Reduced Susceptibility to Neuraminidase Inhibitor Drugs
Nathalie Bastien, Jonathan B. Gubbay, David Richardson, Katrina Sleeman, Larisa V. Gubareva, Yan Li
Abstract
Nathalie Bastien, Jonathan B. Gubbay, David Richardson, Katrina Sleeman, Larisa V. Gubareva, Yan Li
Abstract
The neuraminidase inhibitors (NAIs) oseltamivir and zanamivir have played an essential role in the prophylaxis and treatment of influenza. The residues forming the NA active sites are conserved among influenza A and B viruses ([3][1]). Conserved residues are in direct contact with the substrate or
OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The neuraminidase inhibitors (NAIs) oseltamivir and zanamivir have played an essential role in the prophylaxis and treatment of influenza. The residues forming the NA active sites are conserved among influenza A and B viruses ([3][1]). Conserved residues are in direct contact with the substrate or
Key concepts: Neuraminidase inhibitor, Neuraminidase, Virology, Strain (injury), Influenzavirus B, Microbiology, Orthomyxoviridae, Zanamivir